The purpose of this study is to investigate a new drug that could be a potential new treatment for osteoporosis.
Osteoporosis is a disease that thins and weakens the bones, which causes the bones to become fragile and fracture (break) easily. Anyone can develop osteoporosis, but it is more common in older women after menopause.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!